What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Author:
Affiliation:
1. Professor of Dermatology, Boston University School of Medicine and Roger Williams Medical Center, Providence, RI
Publisher
Oxford University Press (OUP)
Subject
General Medicine,Surgery
Link
http://academic.oup.com/asj/article-pdf/39/Supplement_1/S28/27662673/sjy250.pdf
Reference41 articles.
1. Survival signals and targets for therapy in breast implant-associated ALK–anaplastic large cell lymphoma;Lechner;Clin Cancer Res.,2012
2. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations;Chen;Proc Natl Acad Sci U S A.,2017
3. Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors;Welsch;Eur J Immunol.,2017
4. Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma;Blombery;Haematologica.,2016
5. Genetic subtyping of breast implant-associated anaplastic large cell lymphoma;Oishi;Blood.,2018
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PI3K/AKT inhibitor BEZ-235 targets CCND2 and induces G1 arrest in breast implant-associated anaplastic large cell lymphoma;Leukemia Research;2023-10
2. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL);Annals of Surgical Oncology;2023-07-15
3. Linfoma anaplásico de células gigantes asociado a implantes mamarios;Cirugía Plástica;2023
4. Commentary on: CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant–Associated Anaplastic Large Cell Lymphoma;Aesthetic Surgery Journal;2022-11-16
5. CD30 Regulation of IL-13–STAT6 Pathway in Breast Implant–Associated Anaplastic Large Cell Lymphoma;Aesthetic Surgery Journal;2022-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3